Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04686422 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of a Bulk Fill Resin Composite
A NA study of Dental Caries and Unsatisfactory or Defective Restoration of Tooth, sponsored by Ivoclar Vivadent.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT04686422: Completed NA study of Dental Caries and Unsatisfactory or Defective Restoration of Tooth, sponsored by Ivoclar Vivadent.
NCT04686422 is a NA study of Dental Caries and Unsatisfactory or Defective Restoration of Tooth that has completed, run by Ivoclar Vivadent. The registered enrollment target is 39 participants, below the 721-participant average among 30 other Dental Caries trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04686422, a NA study of Dental Caries and Unsatisfactory or Defective Restoration of Tooth, has completed, sponsored by Ivoclar Vivadent.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to measure the clinical outcomes of Tetric PowerFill Class I and II restorations cured in 3 seconds with the Bluephase PowerCure curing unit.
Primary Outcome
assessed by tests with thermal stimuli and occlusal forces (during biting) determined by VAS (Visual Analog Scale, 0 "No pain at all" - 10 "The worst pain imaginable") following the FDI criteria on a scale from 1 "very good" to 5 "unacceptable"
Conditions Studied
Interventions
- DEVICE Tetric PowerFill
Study Locations (1)
Alabama
- UAB School of Dentistry - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT04686422 record still lists
NCT04686422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 721-participant average among 30 other Dental Caries trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Dental Caries appearing as the primary indexed condition, and to 1 intervention - of which Tetric PowerFill is the first listed.
NCT04686422 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT04686422 about?
NCT04686422 is a clinical study titled "Clinical Evaluation of a Bulk Fill Resin Composite". The purpose of this clinical trial is to measure the clinical outcomes of Tetric PowerFill Class I and II restorations cured in 3 seconds with the Bluephase PowerCure curing unit.
What is the current status of trial NCT04686422?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2017-12-01. Estimated completion is 2021-06-30.
What conditions does trial NCT04686422 study?
This clinical trial studies the following conditions: Dental Caries, Unsatisfactory or Defective Restoration of Tooth.
What interventions are being tested in trial NCT04686422?
The interventions under investigation include: Tetric PowerFill (DEVICE).
Who is sponsoring clinical trial NCT04686422?
This trial is sponsored by Ivoclar Vivadent, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04686422 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Caries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04686422's enrollment target sits among peer trials
39 22nd of 30 higher than 9 of 30 other Dental Caries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dental Caries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Stainless Steel Crowns with Prefabricated Resin Crowns in Primary Molar Teeth
RECRUITING · NA
-
LT Comparative Effectiveness of 2 Caries Treatments
RECRUITING · NA
-
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
RECRUITING · NA
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
Polymer Induced Liquid Precursor (PILP) in Adults in With Dentin Caries
RECRUITING · NA
-
In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI